Showing 1721-1730 of 7023 results for "".
Time to Revamp Your Practice Website
https://practicaldermatology.com/topics/practice-management/time-to-revamp-your-practice-website/18706/Your website is your digital storefront. To optimize the benefit of your site, you must review it frequently to be sure you are making the most of technological advancements and search rankings. Keep an eye toward an outstanding user experience (UX). Learn what you need to know to keep your websiteGalderma, Allergan Rosacea News, Dupilumab Data
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-allergan-rosacea-news-dupilumab-data/18591/Galderma Laboratories launched a new pump dispenser design for Mirvaso (brimonidine) Topical Gel, 0.33. The FDA has accepted Allergan's New Drug Application (NDA) filing for oxymetazoline cream 1.0%, an investigational topical prescription product for the treatment of persistent facial erythema assoThoughts on Superpotent Topical Corticosteroids in Children
https://practicaldermatology.com/topics/psoriasis/thoughts-on-superpotent-topical-corticosteroids-in-children/18684/"I think we've been overtrained that atrophy occurs all the time," says Neil J. Korman, MD. Caution is essential, but super potent topical corticosteroids can be used safely and effectively for pediatric psoriasis patients, he says. Jerry Bagel, MD agrees, in this bonus video from the Clinical ConveAchieving Optimal Outcomes with Laser Surgery
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/achieving-optimal-outcomes-with-laser-surgery/18818/Eric Bernstein, MD discusses a variety of laser and light devices and their benefits in treating a myriad of dermatological conditions as well as for cosmetic concerns. He also shares tips for how to use the devices safely to ensure optimal outcomes and to avoid adverse events.Authority Tags - Protecting Your Content
https://practicaldermatology.com/topics/practice-management/authority-tags-protecting-your-content/18678/Practices need to maintain a strong online presence in order to build brand awareness. Google author tags is one strategy that is emerging as a robust marketing tool that supports building a strong online presence. What are author tags, how do they work, and how do they protect your content? The EkwGold Mettle: Dr. Michael Gold Talks Multifaceted Practice with Dr. Joel Cohen
https://practicaldermatology.com/topics/practice-management/gold-mettle-dr-michael-gold-talks-multifacted-practice-with-dr-joel-cohen/18868/Dr. Michael Gold's thriving Nashville practice includes a busy medical practice, a medical spa, and a research center. Plus, he's involved in teaching and educational ventures globally. How does he do it all—and stay on schedule? Dr. Joel L. Cohen finds out.The Importance of Planning
https://practicaldermatology.com/topics/practice-management/the-importance-of-planning/19082/Failing to plan is planning to fail, say Jay A. Shorr, BA, MBM-C, CAC I-V and Mara Shorr, BS, CAC II-V of The Best Medical Business Solutions. They tell aesthetic practices how to lay the foundation for success in minimally invasive procedures.Hoya ConBio - Medlite Demo
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hoya-conbio-medlite-demo/19460/Quick demo on the benefits on using Medlite and how it can improve your practice.How does chronic AD histopathology evolve from spongiosis-dominant lesions to lichenified, fibrotic plaques?
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/how-does-chronic-ad-histopathology-evolve-from-spongiosis-dominant-lesions-to-lichenified-fibrotic-plaques/48772/Christopher Bunick, MD, FAAD, discusses the roles of the six major cytokines that drive atopic dermatitis pathophysiology: IL-4, IL-13, IL-31, TSLP, IL-22, and IFN-γ.Journal Club: Combination Therapy With Dupilumab and Upadacitinib
https://reachmd.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-combination-therapy-with-dupilumab-and-upadacitinib/32408/Neal Bhatia, MD, FAAD, and Ted Lain, MD, MBA, FAAD, discuss the International Journal of Dermatology article “Combination Therapy With Upadacitinib and Dupilumab for Severe Atopic Dermatitis,” and their own experiences with similar treatment strategies.